Clorox (CLX)
(Delayed Data from NYSE)
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 6:06 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 6:06 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Zacks News
Clorox's (CLX) IGNITE Strategy to Evolve Portfolio Bodes Well
by Zacks Equity Research
Clorox (CLX) benefits from pricing actions and cost-saving initiatives. The company is on track to streamline its operating model to improve efficiency.
Clorox (CLX) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Clorox (CLX) stood at $147.66, denoting a -1.88% change from the preceding trading day.
The Zacks Analyst Blog Highlights Clorox, Grocery Outlet, Molson Coors, Tyson Foods and Pilgrim's Pride
by Zacks Equity Research
Clorox, Grocery Outlet, Molson Coors, Tyson Foods and Pilgrim's Pride are included in this Analyst Blog.
Here's Why Clorox (CLX) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Consumer Staples Stocks to Buy as Inflation Rises in February
by Ritujay Ghosh
Consumer staple stocks like The Clorox Company (CLX), Grocery Outlet Holding Corp. (GO), Molson Coors Beverage Company (TAP), Tyson Foods (TSN) and Pilgrim's Pride Corporation (PPC) are a safe bet during market volatility.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and WD-40 (WDFC) have performed compared to their sector so far this year.
Clorox (CLX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Why Clorox (CLX) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and WD-40 (WDFC) have performed compared to their sector so far this year.
Freshpet (FRPT) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Freshpet's (FRPT) Q4 outlook highlights low-20s net sales growth, robust consumption, operational efficiencies and strategic media investment to boost brand visibility and drive demand.
Best Growth Stocks to Buy for February 13th
by Zacks Equity Research
CLX, ENS and POWL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 13, 2023.
Momentum Monday: Inflation Data, Earnings, and Semiconductors
by Ethan Feller
Want to start the week ahead of the pack? Check out Momentum Mondays
Best Growth Stocks to Buy for February 9th
by Zacks Equity Research
CLX, ENS and POWL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 9, 2023.
Best Momentum Stocks to Buy for February 7th
by Zacks Equity Research
META, AMSC and CLX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 7, 2023.
New Strong Buy Stocks for February 7th
by Zacks Equity Research
AMSC, META, CLX, IPA and KMPR have been added to the Zacks Rank #1 (Strong Buy) List on February 7, 2023.
Best Income Stocks to Buy for February 7th
by Zacks Equity Research
CLX, KMPR and LANC made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 7, 2023.
3 Stocks to Buy Following Guidance Lifts
by Derek Lewis
Earnings season continues its rapid pace, with many companies delivering quarterly results daily. And for those seeking earnings positivity, that's precisely what these three companies have delivered.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Mondelez (MDLZ) have performed compared to their sector so far this year.
Clorox (CLX) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Clorox (CLX) posts solid second-quarter fiscal 2024 results, backed by higher volumes, and gains from pricing actions and cost-saving initiatives.
Clorox (CLX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 100% and 12.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Church & Dwight (CHD) Gears up for Q4 Earnings: What to Note?
by Zacks Equity Research
Church & Dwight (CHD) is likely to have seen growth in Q4 earnings, supported by strategic initiatives and consumer demand despite the potential impacts of increased expenses.
Countdown to Clorox (CLX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Clorox (CLX) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Clorox (CLX) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $144.68, marking a +0.37% move from the previous day.